These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8422302)

  • 1. Phase II trial with ifosfamide in pancreatic cancer.
    Wils JA; Kok T; Wagener DJ; Francois E; Selleslags J; Duez N
    Eur J Cancer; 1993; 29A(2):290. PubMed ID: 8422302
    [No Abstract]   [Full Text] [Related]  

  • 2. Ifosfamide treatment of pancreatic cancer.
    Gad-El-Mawla N; Ziegler JL
    Cancer Treat Rep; 1981; 65(3-4):357-8. PubMed ID: 7237460
    [No Abstract]   [Full Text] [Related]  

  • 3. Ifosfamide plus 5-fluorouracil for treatment of adenocarcinoma of the pancreas.
    Loehrer PJ; Williams SD; Nichols CR
    Cancer Treat Rep; 1987 Nov; 71(11):1115-6. PubMed ID: 3119208
    [No Abstract]   [Full Text] [Related]  

  • 4. Ifosfamide: an active drug in the treatment of adenocarcinoma of the pancreas.
    Loehrer PJ; Williams SD; Einhorn LH; Ansari R
    J Clin Oncol; 1985 Mar; 3(3):367-72. PubMed ID: 3973647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine and ifosfamide in the treatment of unresectable pancreatic adenocarcinoma and refractory testicular cancer.
    Loehrer PJ; Williams SD; Einhorn LH
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):72-5. PubMed ID: 6836331
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ifosfamide chemotherapy ineffective for advanced pancreatic carcinoma].
    Fujiki T; Futatsuki K; Akazawa S; Yamamoto K; Kanda Y; Yamato A; Terashi K; Suda Y
    Gan To Kagaku Ryoho; 1997 Mar; 24(5):569-72. PubMed ID: 9087289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of cell therapy as a means of targeting chemotherapy to inoperable pancreatic cancer.
    Günzburg WH; Salmons B
    Acta Biochim Pol; 2005; 52(3):601-7. PubMed ID: 16175235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium.
    Sutton GP; Blessing JA; DeMars LR; Moore D; Burke TW; Grendys EC
    Gynecol Oncol; 1996 Oct; 63(1):25-7. PubMed ID: 8898163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450.
    Löhr M; Müller P; Karle P; Stange J; Mitzner S; Jesnowski R; Nizze H; Nebe B; Liebe S; Salmons B; Günzburg WH
    Gene Ther; 1998 Aug; 5(8):1070-8. PubMed ID: 10326030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ifosfamide and mesna: marginally active in patients with advanced carcinoma of the pancreas.
    Ajani JA; Abbruzzese JL; Goudeau P; Faintuch JS; Yeomans AC; Boman BM; Nicaise C; Levin B
    J Clin Oncol; 1988 Nov; 6(11):1703-7. PubMed ID: 3141592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifosfamide is an inactive substance in the treatment of pancreatic carcinoma. The Gastrointestinal Tumor Study Group.
    Cancer; 1989 Nov; 64(10):2010-3. PubMed ID: 2509063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of ifosfamide and mesna in refractory adenocarcinoma of the endometrium. A Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Homesley HD; McGuire WP; Adcock L
    Cancer; 1994 Mar; 73(5):1453-5. PubMed ID: 8111713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use and safety of high-dose ifosfamide.
    Holoye PY; Anderson T; Duelge J; Hansen RM; Ritch PS
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):78-86. PubMed ID: 6298946
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of metastatic renal cancer with ifosfamide and mesnum with and without irradiation.
    Fosså SD; Talle K
    Cancer Treat Rep; 1980; 64(10-11):1103-8. PubMed ID: 6780190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ifosfamide in advanced adenocarcinoma of the oesophagus or oesophageal-gastric junction area. Rotterdam Esophageal Tumor Study Group.
    Kok TC; van der Gaast A; Splinter TA; Tilanus HW
    Eur J Cancer; 1991; 27(9):1112-4. PubMed ID: 1835618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial of esorubicin in advanced pancreatic adenocarcinoma.
    Blayney DW; Goldberg DA; Leong LA; Carr BI; Doroshow JH
    Cancer Treat Rep; 1986 May; 70(5):683-4. PubMed ID: 3708621
    [No Abstract]   [Full Text] [Related]  

  • 17. Trofosfamide in patients with pancreatic cancer.
    Schmidt-Sandte W; Dageförde J; Klapdor R; Wagner T; Wiedemann GJ
    Anticancer Res; 1999; 19(4A):2485-7. PubMed ID: 10470179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of inoperable pancreatic carcinoma using a cell-based local chemotherapy: results of a phase I/II clinical trial.
    Salmons B; Löhr M; Günzburg WH
    J Gastroenterol; 2003 Mar; 38 Suppl 15():78-84. PubMed ID: 12698877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group.
    Briasoulis E; Pavlidis N; Terret C; Bauer J; Fiedler W; Schöffski P; Raoul JL; Hess D; Selvais R; Lacombe D; Bachmann P; Fumoleau P
    Eur J Cancer; 2003 Nov; 39(16):2334-40. PubMed ID: 14556925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of ifosfamide and mesna in nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; DiSaia PJ; McGuire WP
    Gynecol Oncol; 1993 Apr; 49(1):48-50. PubMed ID: 8482560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.